From 2008 to 2023, there has been a significant decrease in cystic fibrosis mortality rates and a significant rise in sickle ...

BUFFALO, N.Y. – Drucy S. Borowitz, MD, clinical professor in the Department of Pediatrics in the University at Buffalo School of Medicine and Biomedical Sciences, has received a major national award ...

Cystic fibrosis is a common, fatal genetic disease in which a gene causes the body to produce abnormally thick, sticky mucus. This affects mainly the lungs, causing severe breathing problems, and the ...

Pediatric patients with cystic fibrosis starting triple combination therapy had larger relative improvements in 129Xenon MRI ...

New data shows three triple-combination regimens are "highly effective" for up to 90 percent of cystic fibrosis patients.In what medical researchers are calling a first but very important step for ...

The Division of Pulmonary Medicine within Saint Louis University's Department of Pediatrics cares for children with a variety of acquired and congenital respiratory disorders as well as sleep ...

As a parent, watching a child suffer from a respiratory disorder can be frightening and worrisome. Our respiratory specialists provide compassionate care for a wide-range of pediatric respiratory ...

CLEVELAND, Ohio -- Dr. Michael W. Konstan is the new chairman of the pediatrics department at University Hospitals Case Medical Center’s Rainbow Babies & Children’s Hospital and Case Western Reserve ...

The U.S. Food and Drug Administration today expanded the indication for Symdeko (a combination of tezacaftor/ivacaftor) tablets for treatment of pediatric patients ages 6 years and older with cystic ...

In cystic fibrosis, Pseudomonas aeruginosa is a much-feared pathogen. The bacterium easily colonizes the lungs of people with cystic fibrosis, leading to chronic infections that are almost impossible ...

Therapeutics Market Size accelerated to USD 10.60 billion in 2024, up from USD 9.22 billion in 2023, and is now projected to expand aggressively to USD 35.09 billion by 2033, recording a CAGR of 14.2% ...